Overview
Human Alpha-Gal Syndrome (AGS) Serum for Research
Our Alpha-Gal Syndrome (AGS) Serum is sourced from IRB-consented donors clinically diagnosed with Alpha-Gal Syndrome (AGS). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for inflammation and dermatology-related studies.
Product Features
- Collected from clinically confirmed Alpha-Gal Syndrome (AGS) donors
- Research Use Only (RUO)
- Frozen serum stored at -80?C
- IRB-approved protocols with documented consent
Donor Metadata
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for Alpha-Gal Syndrome (AGS) and inflammatory skin conditions
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Alpha-Gal Syndrome (AGS) plasma is available in a range of standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Protocol and Documentation
Resources and Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.